Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Merger agrmnt [a]
Appointed director
|
|
VYNE Therapeutics Inc. (MNLO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 11/10/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/12/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 05/06/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 11/05/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 08/06/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
| 05/11/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
| 10/31/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 08/01/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
| 05/02/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
| 11/07/2018 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
| 08/01/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
|
|